Sezary Syndrome

Views & Analysis

Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to fight cancer.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.